{"id":"W2125940163","doi":"10.1093/neuonc/nou359","title":"In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; University of Calgary; Alberta Innovates; Killam Trusts; Terry Fox Foundation; V Foundation for Cancer Research","keywords":"Oncolytic virus; Myxoma virus; Glioma; Biology; Cancer research; Virus; Virology; Pharmacology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002200767,0.001069086,0.0009381254,0.001374641,0.0003369213,0.0004464726,0.0004774152,0.0003331834,0.004307501],"category_scores_gemma":[0.0002055498,0.0002657497,0.00053747,0.0009732007,0.0002296919,0.0002472293,0.0002595173,0.0005104046,0.0009571749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004498904,"about_ca_system_score_gemma":0.0007605583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001330909,"about_ca_topic_score_gemma":0.004687459,"domain_scores_codex":[0.9998649,0.00002169614,0.0000109331,0.00003106186,0.00003857974,0.00003273726],"domain_scores_gemma":[0.999876,0.00003303642,0.00002136596,0.000008988196,0.00002767865,0.00003290995],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001424731,0.002073542,0.002175209,0.0009723363,0.0002451425,0.0007255165,0.0001288051,0.00423616,0.9294612,0.000505418,0.002134102,0.05591784],"study_design_scores_gemma":[0.002027288,0.02442799,0.01432019,0.0002055432,0.00119373,0.002346524,0.000154506,0.00602747,0.9173964,0.0003087717,0.03150656,0.00008509332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.949388,0.01884301,0.006936053,0.0005557323,0.00008983857,0.001425653,0.006497792,0.0006765794,0.01558733],"genre_scores_gemma":[0.9574977,0.01658156,0.008728597,0.000331532,0.00004640566,0.0004876022,0.008173513,0.00006952383,0.008083498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004307501,"threshold_uncertainty_score":0.01441008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02904631181734608,"score_gpt":0.2854235973629419,"score_spread":0.2563772855455959,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}